Summary & Overview
HCPCS J1741: Injection, Ibuprofen 100 mg
HCPCS Level II code J1741 denotes an injectable formulation of ibuprofen in a 100 mg dose. As an HCPCS Level II drug code, J1741 identifies the specific administered medication unit for billing and claims adjudication for outpatient and ambulatory settings. Nationally, injectable nonsteroidal anti-inflammatory drugs (NSAIDs) are relevant for acute pain management and perioperative protocols, making accurate coding important for clinical documentation and payer reimbursement workflows.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coding intent, typical sites of service, and areas where benchmarks and policy guidance commonly apply. The publication outlines common billing practices for injectable medications, highlights payer coverage considerations, and summarizes how J1741 is represented in claims line items.
This briefing also identifies where input data is available and where it is not. It is designed to help billing managers, revenue cycle staff, and policy analysts understand the code’s clinical role, the payer landscape nationally, and the types of benchmarks and policy updates that typically affect injectable drug billing. Data not available in the input is noted where relevant in supporting sections.
Billing Code Overview
HCPCS Level II code J1741 represents an injection of ibuprofen, 100 mg. The service involves administration of an intravenous or intramuscular nonsteroidal anti-inflammatory medication formulated as a 100 mg injectable dose. The service type is injectable medication administration. The typical site of service includes outpatient infusion centers, hospital outpatient departments, ambulatory surgical centers, and physician offices where injections are provided.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center or ambulatory surgical center with acute localized musculoskeletal pain (for example, postoperative pain after orthopedic procedures or acute soft-tissue injury) where intravenous or intramuscular administration of a nonsteroidal anti-inflammatory agent is clinically indicated. The treating clinician (emergency physician, hospitalist, anesthesiologist, or orthopedic surgeon) orders J1741 for single-dose parenteral ibuprofen, 100 mg, to provide rapid analgesia and anti-inflammatory effect when oral therapy is contraindicated or not tolerated. The clinical workflow includes patient assessment (vital signs, allergy history, medication reconciliation), informed consent for parenteral NSAID, verification of renal function and bleeding risk, preparation and administration by a registered nurse or qualified clinician, monitoring for adverse effects for an appropriate observation period, and documentation of dose, route, lot number, and patient response in the medical record. Typical sites of service are outpatient infusion centers, emergency departments, ambulatory surgery centers, and inpatient hospital units when parenteral ibuprofen is used as part of multimodal pain management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered to any patient | Use when part of a single-use vial is discarded after preparing the ordered dose of . |